Find Moxidectin manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

USP

0

JP

FINISHED DOSAGE FORMULATIONS

0

Australia

0

South Africa

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 113507-06-5, Proheart 6, Ngu5h31yo9, Cl 301,423, Nsc-760424, (1r,4s,4'e,5's,6r,6's,8r,10e,13r,14e,16e,20r,21r,24s)-21,24-dihydroxy-4'-methoxyimino-5',11,13,22-tetramethyl-6'-[(e)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one
Molecular Formula
C37H53NO8
Molecular Weight
639.8  g/mol
InChI Key
YZBLFMPOMVTDJY-LSGXYNIPSA-N
FDA UNII
NGU5H31YO9

Moxidectin
Moxidectin is a macrocyclic lactone derived from Streptomyces cyanogriseus with antiparasitic activity. Upon administration, moxidectin may bind to glutamate-gated chloride channels (GluCl), gamma-aminobutyric acid (GABA) receptors and/or ATP-binding cassette (ABC) transporters expressed on nematode neurons and pharyngeal muscle cells. As a result, neurons or muscle cells remain at either hyperpolarization or depolarization state, thereby resulting in muscle paralysis. Moxidectin reduces the motility and fertility of the parasite and its excretion of immunomodulatory proteins, and inhibits the release of microfilariae.
1 2D Structure

Moxidectin

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(1R,4S,4'E,5'S,6R,6'S,8R,10E,13R,14E,16E,20R,21R,24S)-21,24-dihydroxy-4'-methoxyimino-5',11,13,22-tetramethyl-6'-[(E)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one
2.1.2 InChI
InChI=1S/C37H53NO8/c1-21(2)14-25(6)33-26(7)31(38-42-8)19-36(46-33)18-29-17-28(45-36)13-12-23(4)15-22(3)10-9-11-27-20-43-34-32(39)24(5)16-30(35(40)44-29)37(27,34)41/h9-12,14,16,21-22,26,28-30,32-34,39,41H,13,15,17-20H2,1-8H3/b10-9+,23-12+,25-14+,27-11+,38-31+/t22-,26-,28+,29-,30-,32+,33+,34+,36-,37+/m0/s1
2.1.3 InChI Key
YZBLFMPOMVTDJY-LSGXYNIPSA-N
2.1.4 Canonical SMILES
CC1CC(=CCC2CC(CC3(O2)CC(=NOC)C(C(O3)C(=CC(C)C)C)C)OC(=O)C4C=C(C(C5C4(C(=CC=C1)CO5)O)O)C)C
2.1.5 Isomeric SMILES
C[C@@H]\1C/C(=C/C[C@@H]2C[C@@H](C[C@@]3(O2)C/C(=N\OC)/[C@@H]([C@H](O3)/C(=C/C(C)C)/C)C)OC(=O)[C@@H]4C=C([C@H]([C@@H]5[C@]4(/C(=C/C=C1)/CO5)O)O)C)/C
2.2 Other Identifiers
2.2.1 UNII
NGU5H31YO9
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 5-hydroxymilbemycin Beta7

2. Cl 301,423

3. Cl 301423

4. Cydectin

5. Milbeknock

6. Milbemectin

7. Milbemycin A3

8. Milbemycin A4

9. Milbemycin Alpha1

10. Milbemycin Alpha10

11. Milbemycin Alpha11

12. Milbemycin Alpha13

13. Milbemycin Alpha14

14. Milbemycin Alpha15

15. Milbemycin Alpha2

16. Milbemycin Alpha3

17. Milbemycin Alpha4

18. Milbemycin Alpha5

19. Milbemycin Alpha6

20. Milbemycin Alpha7

21. Milbemycin Alpha8

22. Milbemycin Alpha9

23. Milbemycin B

24. Milbemycin Beta1

25. Milbemycin Beta12

26. Milbemycin Beta2

27. Milbemycin Beta3

28. Milbemycin D

29. Milbemycins

30. Mixture Of Milbemycins A3 And A4

2.3.2 Depositor-Supplied Synonyms

1. 113507-06-5

2. Proheart 6

3. Ngu5h31yo9

4. Cl 301,423

5. Nsc-760424

6. (1r,4s,4'e,5's,6r,6's,8r,10e,13r,14e,16e,20r,21r,24s)-21,24-dihydroxy-4'-methoxyimino-5',11,13,22-tetramethyl-6'-[(e)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one

7. Cl-301,423

8. (6r,25s)-5-o-demethyl-28-deoxy-25-((e)-1,3-dimethyl-1-butenyl)-6,28-epoxy-23-oxomilbemycin B 23-(e)-(o-methyloxime)

9. Milbemycin B

10. Moxidectina

11. Moxidectine

12. Moxidectinum

13. Moxidectine [inn-french]

14. Moxidectinum [inn-latin]

15. Unii-ngu5h31yo9

16. Moxidectina [inn-spanish]

17. Moxidectin [usan:inn:ban]

18. Moxidectin (tn)

19. (2ae,2'r,4e,4'e,5's,6r,6's,8e,11r,15s,17ar,20r,20ar,20bs)-6'-[(1e)-1,3-dimethylbut-1-enyl]-20,20b-dihydroxy-4'-(methoxyimino)-5',6,8,19-tetramethyl-3',4',5',6,6',7,10,11,14,15,17a,20,20a,20b-tetradeca

20. Hydrospiro[2h,17h-11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-17-one

21. Moxidectin [mi]

22. Moxidectin (usp/inn)

23. Moxidectin [inn]

24. Moxidectin [usan]

25. Moxidectin [mart.]

26. Moxidectin [usp-rs]

27. Moxidectin [who-dd]

28. Moxidectin For Veterinary Use

29. Moxidectin [green Book]

30. Chembl2104415

31. Dtxsid5037577

32. Moxidectin [orange Book]

33. Schembl13112872

34. Chebi:183811

35. Moxidectin [usp Monograph]

36. Advocate Component Moxidectin

37. Hy-b0777

38. Mfcd00866560

39. S3713

40. Akos025401990

41. Zinc253476173

42. Ccg-270317

43. Db11431

44. Moxidectin Component Of Advocate

45. Nsc 760424

46. Moxidectin [ema Epar Veterinary]

47. (2ae,4e,5'r,6r,6's,8e,11r,13s,15s,17ar,20r,20ar,20bs)-6'-((e)-1,3-dimethyl-1-butenyl)-5',6,6',7,10,11,14,15,17a,20,20a,20b-dodecahydro-20,20b-dihydroxy-5',6,8,19-tetramethylspiro(11,15-methano-2h,13h,17h-furo(4,3,2-pq)(2,6)benzodioxacyclooctadecin-13,2'-(2h)pyran)-4',17(3'h)-dione 4'-(e)-(o-methyloxime)

48. Ac-27773

49. As-17881

50. Moxidectin 100 Microg/ml In Acetonitrile

51. Cl-301423

52. M3136

53. D05084

54. Moxidectin, Vetranal(tm), Analytical Standard

55. 507m065

56. Moxidectin For Veterinary Use [ep Monograph]

57. Moxidectin, European Pharmacopoeia (ep) Reference Standard

58. Moxidectin, United States Pharmacopeia (usp) Reference Standard

59. Moxidectin, Pharmaceutical Secondary Standard; Certified Reference Material

60. Moxidectin For System Suitability, European Pharmacopoeia (ep) Reference Standard

61. Milbemycin B, 5-o-demethyl-28-deoxy-25-((1e)-1,3-dimethyl-1-butenyl)-6,28-epoxy-23-(methoxyimino)-, (6r,23e,25s)-

62. Milbemycin B, 5-o-demethyl-28-deoxy-25-(1,3-dimethyl-1-butenyl)-6,28-epoxy-23-(methoxyimino)-, (6r,23e,25s(e))-

63. Milbemycin B, 5-o-demethyl-28-deoxy-25-(1,3-dimethyl-1-butenyl)-6,28-epoxy-23-(methoxyimino)-,(6r,23e,25s(e))-

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 639.8 g/mol
Molecular Formula C37H53NO8
XLogP34.3
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count9
Rotatable Bond Count3
Exact Mass639.37711765 g/mol
Monoisotopic Mass639.37711765 g/mol
Topological Polar Surface Area116 Ų
Heavy Atom Count46
Formal Charge0
Complexity1340
Isotope Atom Count0
Defined Atom Stereocenter Count10
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count5
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Moxidectin is indicated for the treatment of river blindness, also called onchocerciasis, in patients aged 12 years and older. River blindness is caused by a parasitic worm _Onchocerca volvulus_ and it is manifested as severe itching, disfiguring skin conditions and visual impairment caused by the worm's larvae. The transmission of _Onchocerca volvulus_ is performed person to person by black flies that breed in fast-flowing rivers in sub-Saharan Africa, Yemen and South and Central America. The larvae released by the adult parasite invade skin and eyes where they can produce the severe disease manifestations.


FDA Label


5 Pharmacology and Biochemistry
5.1 Pharmacology

Moxidectin has been reported to be highly effective against _Onchocerca volvulus_ when compared to ivermectin. When moxidectin was administered in infected individuals, the microfilarial load in the skin was lower even when compared to the current therapy, ivermectin. The levels of microfilarial got reduced to an undetectable level while being safe to be used in mass drug administration.


5.2 MeSH Pharmacological Classification

Anthelmintics

Agents that kill parasitic worms. They are used therapeutically in the treatment of HELMINTHIASIS in man and animal. (See all compounds classified as Anthelmintics.)


Antinematodal Agents

Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice. (See all compounds classified as Antinematodal Agents.)


Insecticides

Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)


5.3 ATC Code

P - Antiparasitic products, insecticides and repellents

P02 - Anthelmintics

P02C - Antinematodal agents

P02CX - Other antinematodals

P02CX03 - Moxidectin


5.4 Absorption, Distribution and Excretion

Absorption

The penetration of moxidectin in the parasite is not restricted as this compound is a very poor substrate of p-glycoprotein, which is vital for the reduction of the uptake of lipophilic compounds from the GI tract and for the increase in biliary, intestinal and renal secretion. After oral administration of moxidectin, the plasma maximal concentration of 70.4 mg/kg was reached after 0.37 day with a reported AUC of 363.6 mcg/day/ml. It is also important to mention that oral bioavailability is enhanced with the co-administration with lipids.


Route of Elimination

When moxidectin is orally administered, 2% of the dose is eliminated unchanged in the feces within 72 hours. Renal elimination is negligible.


Volume of Distribution

Moxidectin presents a larger volume of distribution and mean residence time when compared to ivermectin. The reported volume of distribution is of 1.2 l/kg.


Clearance

The apparent clearance of moxidectin is 3.5 L/hour.


5.5 Metabolism/Metabolites

Reports have registered enzymatic modification in humans and in nematodes. In the case of moxidectin, there has been registered C29-30- and C14-mono-hydroxymethyl derivatives mainly by the cytochrome CYP3A and CYP2B. The metabolism of moxidectin is considered to contribute to a small extent to the elimination. Some other metabolites formed are O-demethyl-dihydroxy metabolites. The metabolism of the of moxidectin is not major as the major residue in fat, liver, kidney and muscle is the unchanged moxidectin.


5.6 Biological Half-Life

Moxidectin reporter terminal half-life is 20.2 days.


5.7 Mechanism of Action

Moxidectin selectively binds to the parasite's GABA-A and glutamate-gated chloride ion channels which are vital for the function of invertebrate nerve and muscle cells. It presents activity against the parasite but it does not kill him. Once moxidectin is bound, there is an increased permeability leading to an influx of chloride ions and flaccid paralysis of the parasite.


API SUPPLIERS

read-more
read-more

01

Rochem International Inc

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothRochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

Flag U.S.A
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF VMF arrow-down AUDIT
Rochem

02

Livzon New North River Pharmaceuti...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

PEGS Boston Summit
Not Confirmed
arrow

Livzon New North River Pharmaceuti...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
PEGS Boston Summit
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

03

Livzon Group Fuzhou Fuxing Pharmac...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

PEGS Boston Summit
Not Confirmed
arrow

Livzon Group Fuzhou Fuxing Pharmac...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
PEGS Boston Summit
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF EU-WC NDC arrow-down KDMF VMF arrow-down Others AUDIT arrow-down
blank

04

Zhejiang Hisun Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

PEGS Boston Summit
Not Confirmed
arrow

Zhejiang Hisun Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
PEGS Boston Summit
Not Confirmed
USDMF CEP/COS arrow-down JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
blank

05

Vega

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

PEGS Boston Summit
Not Confirmed
arrow

Vega

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
PEGS Boston Summit
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

06

ZOETIS MANUFACTURING ITALIA S.R.L....

Italy

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

PEGS Boston Summit
Not Confirmed
arrow

ZOETIS MANUFACTURING ITALIA S.R.L....

Italy

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
PEGS Boston Summit
Not Confirmed
USDMF CEP/COS arrow-down JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

07

Zhejiang Hisun Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

PEGS Boston Summit
Not Confirmed
arrow

Zhejiang Hisun Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
PEGS Boston Summit
Not Confirmed
USDMF CEP/COS Inactive-api JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
blank

08

Jiangsu Lingyun Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

PEGS Boston Summit
Not Confirmed
arrow

Jiangsu Lingyun Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
PEGS Boston Summit
Not Confirmed
USDMF CEP/COS arrow-down JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

09

Diligent Life Care

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

PEGS Boston Summit
Not Confirmed
arrow

Diligent Life Care

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
PEGS Boston Summit
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

10

Zhejiang Hisoar Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

PEGS Boston Summit
Not Confirmed
arrow
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-moreread-more

01

PEGS Boston Summit
Not Confirmed

01

PEGS Boston Summit
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 35909

Submission : 2021-05-30

Status : Active

Type : II

blank

02

PEGS Boston Summit
Not Confirmed

02

PEGS Boston Summit
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 29420

Submission : 2015-05-19

Status : Active

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

CEP/COS

read-more
read-moreread-more

01

PEGS Boston Summit
Not Confirmed
arrow

02

PEGS Boston Summit
Not Confirmed
arrow

03

PEGS Boston Summit
Not Confirmed
arrow

04

PEGS Boston Summit
Not Confirmed
arrow

05

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Certificate Number : R0-CEP 2010-367 - Rev 00

Status : Withdrawn by Holder

Issue Date : 2012-05-22

Type : Chemical

Substance Number : 1656

blank

06

PEGS Boston Summit
Not Confirmed
arrow
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-moreread-more

01

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

MOXIDECTIN

NDC Package Code : 57885-0010

Start Marketing Date : 2013-10-08

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

02

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

MOXIDECTIN

NDC Package Code : 51187-0005

Start Marketing Date : 2019-09-09

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

03

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

MOXIDECTIN

NDC Package Code : 70952-001

Start Marketing Date : 2018-04-17

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

04

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

MOXIDECTIN

NDC Package Code : 42513-0018

Start Marketing Date : 2021-12-05

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

05

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

MOXIDECTIN

NDC Package Code : 42513-0018

Start Marketing Date : 2021-12-05

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

06

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

MOXIDECTIN

NDC Package Code : 20076-1245

Start Marketing Date : 2015-01-05

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

07

Zoetis Inc.

U.S.A
PEGS Boston Summit
Not Confirmed
arrow

Zoetis Inc.

U.S.A
arrow
PEGS Boston Summit
Not Confirmed

MOXIDECTIN

NDC Package Code : 54771-7016

Start Marketing Date : 2021-08-11

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

VMF

read-more
read-moreread-more

06

Zoetis Inc

U.S.A
arrow
PEGS Boston Summit
Not Confirmed

07

Zoetis Inc

U.S.A
arrow
PEGS Boston Summit
Not Confirmed

08

Zoetis Inc

U.S.A
arrow
PEGS Boston Summit
Not Confirmed

09

Zoetis Inc

U.S.A
arrow
PEGS Boston Summit
Not Confirmed

10

Zoetis Inc

U.S.A
arrow
PEGS Boston Summit
Not Confirmed
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothRochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

Flag U.S.A
Digital Content Digital Content

Moxidectin

About the Company : Rochem, established in 1994, is a global distributor of pharmaceutical, food, nutritional, and animal health ingredients, sourcing high-quality products from China. Headquartered i...

Rochem, established in 1994, is a global distributor of pharmaceutical, food, nutritional, and animal health ingredients, sourcing high-quality products from China. Headquartered in Hauppauge, New York, it operates 16 offices worldwide. Rochem’s operations are fully cGMP compliant and have been audited by the USFDA and several multinational organizations. The company also trains and audits its partners to ensure FDA-compliant technologies and systems. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Rochem

02

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Moxidectin

About the Company : Anhui Sinotech Industrial Co.,Ltd is specially engaged in international marketing of food/feed additive,pesticides and chemicals. We are devoted ourselves to make the life better,a...

Anhui Sinotech Industrial Co.,Ltd is specially engaged in international marketing of food/feed additive,pesticides and chemicals. We are devoted ourselves to make the life better,always ready to provide top quality products combined with competitive price and comprehensive commercial service. By continuously efforts,the company has already established stable long-term business relationships with hundreds of oversea customers and domestic suppliers.Our products has exported to many countries and regions, including Southeast Asia,South America, Europe,etc.
blank

03

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Moxidectin

About the Company : Diligent Life Care, established in 2017, is a prominent API (Active Pharmaceutical Ingredient) manufacturing entity. The manufacturing base is strategically located in Vatva GIDC, ...

Diligent Life Care, established in 2017, is a prominent API (Active Pharmaceutical Ingredient) manufacturing entity. The manufacturing base is strategically located in Vatva GIDC, Ahmedabad, Gujarat, with a corresponding marketing office situated in Mumbai. Founded by a group of experts with established credentials in research, manufacturing, and the global market, DILIGENT LIFE CARE operates with the intention to discover and deliver APIs in niche pharmaceutical and veterinary markets
blank

04

Flavine

U.S.A
PEGS Boston Summit
Not Confirmed
arrow

Flavine

U.S.A
arrow
PEGS Boston Summit
Not Confirmed

Moxidectin

About the Company : Flavine established itself as a marketing and distribution company for Active Pharmaceutical Ingredients (APIs) and Intermediates for the human and veterinary health industries. T...

Flavine established itself as a marketing and distribution company for Active Pharmaceutical Ingredients (APIs) and Intermediates for the human and veterinary health industries. Today, Flavine has become a truly global enterprise that has built a worldwide network of top tier manufacturers of APIs, Intermediates and Finished Dose Pharmaceuticals supporting customers as well as its own developments in diverse regulated markets.
blank

05

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Moxidectin

About the Company : Established in 2011 and situated in Hangzhou, Zhejiang, China, Hangzhou Longshine Bio-Tech CO., Ltd is dedicated to providing services for pharmaceutical and chemical products, cat...

Established in 2011 and situated in Hangzhou, Zhejiang, China, Hangzhou Longshine Bio-Tech CO., Ltd is dedicated to providing services for pharmaceutical and chemical products, catering to both export and import markets. The company consists of two primary business departments: the Professional Sourcing/Product Team and the Quality Team. Backed by experienced partners, Longshine has evolved into a trustworthy supplier of high-quality products and received ISO9001:2008 certification in 2017.
blank

06

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Moxidectin

About the Company : Hefei TNJ Chemical Industry, established in 2001, is a key chemical manufacturer and supplier in China. In 2001, three young chemists from a local large state-owned chemical facto...

Hefei TNJ Chemical Industry, established in 2001, is a key chemical manufacturer and supplier in China. In 2001, three young chemists from a local large state-owned chemical factory established TNJ Chemical by starting from producing PVP products. By taking advantage of technology innovation, TNJ made fast and steady development in PVP. Meanwhile, in order to further enhance comprehensive competence, TNJ begun to seek for products diversity and invested more chemical lines to meet market demands. Up to 2015, TNJ owns key products of more than 60 which covers four fields: Chemicals, Food, Pharmaceutical and Personal care.
blank

07

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Moxidectin

About the Company : HISUN is one of the local leading pharmaceutical companies in China. It was founded in 1956; And this year would be our 60th anniversary. Over past 59 years, our company has always...

HISUN is one of the local leading pharmaceutical companies in China. It was founded in 1956; And this year would be our 60th anniversary. Over past 59 years, our company has always had positive revenue since it was established. HISUN was publicly shared in 2000 in Shanghai Stock Exchange(Our Stock No. 600267). We are the largest antibiotics, anticancer drugs production supplier. We provide diverse products and services. Our research channels cover many indications extensively: like anticancer, cardiovascular, anti-infective, anti-parasitics, immunosuppressant, etc.
blank

08

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Moxidectin

About the Company : It is a new biotech factory which was builted in 2012 by Jiangsu Lingyun Pharmaceutical Co., Ltd in Huai'an, Jiangsu Province. It covers an area of 135, 00 square meters and is con...

It is a new biotech factory which was builted in 2012 by Jiangsu Lingyun Pharmaceutical Co., Ltd in Huai'an, Jiangsu Province. It covers an area of 135, 00 square meters and is constructed according to GMP requirements. The line covers fermentation, extraction, synthesis, refining and packing. Willing Bio-Tech has obtained Chinese GMP certificate and passed USA FDA inspection in 2017. With good management system from R&D to production and long term cooperation with renowned domestic research institutes and universities, we have strong R&D capability. We also have established complete quality management system and enjoy good reputation.
blank

09

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Moxidectin

About the Company : Manus Aktteva Biopharma LLP, an ISO 9001:2015 certified organization is a well informed, highly efficient, swiftly functioning competitive sourcing entity. We serve private, insti...

Manus Aktteva Biopharma LLP, an ISO 9001:2015 certified organization is a well informed, highly efficient, swiftly functioning competitive sourcing entity. We serve private, institutional and corporate clients worldwide in the field of Pharmaceuticals & Nutraceuticals. We combine our contacts, their expertise and core competency with our operations to deliver superior pharmaceutical sourcing solutions to our customers. Having our base in India, Manus Aktteva Biopharma LLP has been serving clients in more than 50 countries.
blank

10

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Moxidectin

About the Company : QINGDAO QINGMEI BIOTECH(hereinafter referred to as Qingmei) is a specialized pharmaceutical company founded by DAYON INTERNATIONAL HOLDING LIMITED, which is to expand international...

QINGDAO QINGMEI BIOTECH(hereinafter referred to as Qingmei) is a specialized pharmaceutical company founded by DAYON INTERNATIONAL HOLDING LIMITED, which is to expand international business and strategic cooperation with suppliers. The company is located in the beautiful coastal city of Qingdao, near City Hall and the May Fourth Square, and also close to the port, so that it has convenient traffic conditions for trade. The company's business focuses on the development and promotion of the pharmaceutical chemicals, animal health, food additives, plant extracts, cosmetic raw materials, intermediates and other fine chemicals.
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 113507-06-5 / Moxidectin API manufacturers, exporters & distributors?

Moxidectin manufacturers, exporters & distributors 1

70

PharmaCompass offers a list of Moxidectin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Moxidectin manufacturer or Moxidectin supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Moxidectin manufacturer or Moxidectin supplier.

API | Excipient name

Moxidectin

Synonyms

113507-06-5, Proheart 6, Ngu5h31yo9, Cl 301,423, Nsc-760424, (1r,4s,4'e,5's,6r,6's,8r,10e,13r,14e,16e,20r,21r,24s)-21,24-dihydroxy-4'-methoxyimino-5',11,13,22-tetramethyl-6'-[(e)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one

Cas Number

113507-06-5

Unique Ingredient Identifier (UNII)

NGU5H31YO9

About Moxidectin

Moxidectin is a macrocyclic lactone derived from Streptomyces cyanogriseus with antiparasitic activity. Upon administration, moxidectin may bind to glutamate-gated chloride channels (GluCl), gamma-aminobutyric acid (GABA) receptors and/or ATP-binding cassette (ABC) transporters expressed on nematode neurons and pharyngeal muscle cells. As a result, neurons or muscle cells remain at either hyperpolarization or depolarization state, thereby resulting in muscle paralysis. Moxidectin reduces the motility and fertility of the parasite and its excretion of immunomodulatory proteins, and inhibits the release of microfilariae.

Moxidectin Manufacturers

A Moxidectin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Moxidectin, including repackagers and relabelers. The FDA regulates Moxidectin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Moxidectin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Moxidectin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Moxidectin Suppliers

A Moxidectin supplier is an individual or a company that provides Moxidectin active pharmaceutical ingredient (API) or Moxidectin finished formulations upon request. The Moxidectin suppliers may include Moxidectin API manufacturers, exporters, distributors and traders.

click here to find a list of Moxidectin suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Moxidectin USDMF

A Moxidectin DMF (Drug Master File) is a document detailing the whole manufacturing process of Moxidectin active pharmaceutical ingredient (API) in detail. Different forms of Moxidectin DMFs exist exist since differing nations have different regulations, such as Moxidectin USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Moxidectin DMF submitted to regulatory agencies in the US is known as a USDMF. Moxidectin USDMF includes data on Moxidectin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Moxidectin USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Moxidectin suppliers with USDMF on PharmaCompass.

Moxidectin CEP

A Moxidectin CEP of the European Pharmacopoeia monograph is often referred to as a Moxidectin Certificate of Suitability (COS). The purpose of a Moxidectin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Moxidectin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Moxidectin to their clients by showing that a Moxidectin CEP has been issued for it. The manufacturer submits a Moxidectin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Moxidectin CEP holder for the record. Additionally, the data presented in the Moxidectin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Moxidectin DMF.

A Moxidectin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Moxidectin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Moxidectin suppliers with CEP (COS) on PharmaCompass.

Moxidectin NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Moxidectin as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Moxidectin API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Moxidectin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Moxidectin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Moxidectin NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Moxidectin suppliers with NDC on PharmaCompass.

Moxidectin GMP

Moxidectin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Moxidectin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Moxidectin GMP manufacturer or Moxidectin GMP API supplier for your needs.

Moxidectin CoA

A Moxidectin CoA (Certificate of Analysis) is a formal document that attests to Moxidectin's compliance with Moxidectin specifications and serves as a tool for batch-level quality control.

Moxidectin CoA mostly includes findings from lab analyses of a specific batch. For each Moxidectin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Moxidectin may be tested according to a variety of international standards, such as European Pharmacopoeia (Moxidectin EP), Moxidectin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Moxidectin USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty